Sustained Response to Entrectinib in an Infant With a Germline ALKAL2 Variant and Refractory Metastatic Neuroblastoma With Chromosomal 2p Gain and Anaplastic Lymphoma Kinase and Tropomyosin Receptor Kinase Activation.
Diana TreisGanesh UmapathySusanne FranssonJikui GuanPatricia Mendoza-GarcíaJoachim Tetteh SiawSandra WessmanLena Gordon MurkesJakob J E StenmanAnna DjosLotta H M ElfmanJohn Inge JohnsenBengt HallbergRuth H PalmerTommy MartinssonPer KognerPublished in: JCO precision oncology (2022)